Location: Stockholm, Sweden
CIK: 0001381843 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 6, 2026
Total Value: $313M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | 31,133 | $33.46M | 10.7% | $707.31 | +35.1% | COM | 532457108 |
| ABBV | AbbVie Inc | 108,181 | $24.72M | 7.9% | $176.08 | +29.2% | COM | 00287Y109 |
| MRK | Merck & Co. Inc | 195,768 | $20.61M | 6.6% | $98.68 | -5.5% | COM | 58933Y105 |
| TMO | Thermo Fisher Scientific Corp | 29,915 | $17.33M | 5.5% | $519.30 | +8.8% | COM | 883556102 |
| NBIX | Neurocrine Biosciences Inc | 94,796 | $13.44M | 4.3% | $130.83 | +10.7% | COM | 64125C109 |
| ISRG | Intuitive Surgical Inc | 22,322 | $12.64M | 4.0% | $542.50 | -1.9% | COM NEW | 46120E602 |
| ONC | BEONE MEDICINES LTD-ADR | 40,432 | $12.28M | 3.9% | $222.26 | — | SPONSORED ADS | 07725L102 |
| BBIO | Bridgebio Pharma Inc | 141,296 | $10.81M | 3.4% | $31.34 | +109.5% | COM | 10806X102 |
| VRTX | Vertex Pharmaceuticals Inc | 22,984 | $10.42M | 3.3% | $422.97 | +1.9% | COM | 92532F100 |
| BSX | Boston Scientific Corp | 108,682 | $10.36M | 3.3% | $74.66 | +31.3% | COM | 101137107 |
| SYK | Stryker Corporation | 26,835 | $9.432M | 3.0% | $324.64 | +12.0% | COM | 863667101 |
| CVS | CVS HEALTH CORP | 106,518 | $8.453M | 2.7% | $78.67 | 0.0% | COM | 126650100 |
| KRYS | Krystal Biotech, Inc | 33,853 | $8.346M | 2.7% | $151.49 | +38.9% | COM | 501147102 |
| COR | Cencora Inc | 23,773 | $8.029M | 2.6% | $208.00 | +63.8% | COM | 03073E105 |
| IONS | IONIS PHARMACEUTICALS INC | 92,377 | $7.308M | 2.3% | $75.30 | 0.0% | COM | 462222100 |
| RVMD | REVOLUTION Medicines Inc | 90,184 | $7.183M | 2.3% | $47.24 | +38.8% | COM | 76155X100 |
| AMGN | Amgen Inc | 21,903 | $7.169M | 2.3% | $285.23 | +10.8% | COM | 031162100 |
| MIRM | Mirum Pharmaceuticals Inc | 89,685 | $7.084M | 2.3% | $36.30 | +97.7% | COM | 604749101 |
| INCY | INCYTE CORP | 70,851 | $6.998M | 2.2% | $96.76 | 0.0% | COM | 45337C102 |
| NAMS | NewAmsterdam Pharma Co NV | 197,036 | $6.912M | 2.2% | $19.94 | +82.5% | ORDINARY SHARES | N62509109 |
| ALKS | Alkermes PLC | 242,473 | $6.784M | 2.2% | $26.70 | +12.2% | SHS | G01767105 |
| IRTC | iRhythm Technologies Inc | 37,579 | $6.668M | 2.1% | $129.88 | +36.4% | COM | 450056106 |
| GILD | Gilead Sciences Inc | 50,796 | $6.235M | 2.0% | $101.28 | +19.4% | COM | 375558103 |
| UFPT | UFP Technologies Inc | 22,986 | $5.104M | 1.6% | $277.76 | -22.9% | COM | 902673102 |
| INSM | INSMED INC | 27,873 | $4.851M | 1.5% | $182.48 | 0.0% | COM PAR $.01 | 457669307 |
| CAH | Cardinal Health Inc | 23,470 | $4.823M | 1.5% | $78.17 | +140.1% | COM | 14149Y108 |
| ABVX | ABIVAX SA | 31,590 | $4.26M | 1.4% | $134.85 | — | SPONSORED ADS | 00370M103 |
| CELC | CELCUITY INC | 41,831 | $4.172M | 1.3% | $44.74 | +83.7% | COM | 15102K100 |
| IRON | Disc medicine inc | 47,967 | $3.809M | 1.2% | $54.24 | +55.8% | COM | 254604101 |
| IDYA | IDEAYA BIOSCIENCES INC | 97,438 | $3.368M | 1.1% | $31.88 | 0.0% | COM | 45166A102 |
| UNH | Universal Health Services Inc | 14,636 | $3.191M | 1.0% | $492.66 | -31.6% | COM | 91324P102 |
| CMPX | COMPASS THERAPEUTICS INC | 584,332 | $3.138M | 1.0% | $4.62 | 0.0% | COM | 20454B104 |
| SLNO | Soleno Therapeutics Inc | 62,735 | $2.905M | 0.9% | $58.22 | -5.8% | COM | 834203309 |
| ACLX | Arcellx Inc | 41,717 | $2.72M | 0.9% | $67.60 | +18.0% | COMMON STOCK | 03940C100 |
| DXCM | Dexcom Inc | 39,722 | $2.636M | 0.8% | $97.28 | -33.5% | COM NEW | 252131107 |
| AUTL | Autolus Therapeutics PLC | 1,169,634 | $2.328M | 0.7% | $2.89 | — | SPON ADS | 05280R100 |
| BCAX | BICARA THERAPEUTICS INC | 111,363 | $1.874M | 0.6% | $12.52 | +36.4% | COM | 055477103 |
| CRBP | Corbus Pharmaceuticals Holding | 107,255 | $873K | 0.3% | $20.42 | -39.6% | COM | 21833P301 |
| PYXS | PYXIS ONCOLOGY INC | 617,245 | $710K | 0.2% | $3.53 | 0.0% | COMMON STOCK | 747324101 |